Meaning in life and risk of cognitive impairment: A 9-Year prospective study in 14 countries.


Journal

Archives of gerontology and geriatrics
ISSN: 1872-6976
Titre abrégé: Arch Gerontol Geriatr
Pays: Netherlands
ID NLM: 8214379

Informations de publication

Date de publication:
Historique:
received: 03 10 2019
revised: 31 01 2020
accepted: 17 02 2020
pubmed: 18 3 2020
medline: 4 11 2020
entrez: 18 3 2020
Statut: ppublish

Résumé

A meaningful and purpose-driven life is associated with better health outcomes. We test whether meaning in life is associated with risk of cognitive impairment using data from a large, multi-national study. Participants (N = 22,514) were from the Survey of Health, Ageing and Retirement in Europe (SHARE). Participants from 14 countries reported on their meaning in life. Cognitive impairment was derived from performance on cognitive tasks administered at baseline and at up to three follow-up waves (waves 2-6 assessed between 2010-2015). Lack of meaning in life was associated with a more than 20 % increased risk of incident cognitive impairment over the up to 9-year follow-up (Hazard Ratio = 1.24; 95 % Confidence Interval = 1.17-1.31). Further, compared to participants who reported often feeling meaning in life, participants who reported never feeling meaning in life were at an approximately 75 % increased risk of impairment (Hazard Ratio = 1.75, 95 % Confidence Interval = 1.19-2.57). The association between meaning in life and risk of cognitive impairment was apparent across four regions of Europe (Northern, Southern, Eastern, Western) and in Israel and was not moderated by sociodemographic characteristics. Reporting lower meaning in one's life is associated with risk of incident cognitive impairment. Meaning may be a potential target of intervention for healthier cognitive aging.

Sections du résumé

BACKGROUND
A meaningful and purpose-driven life is associated with better health outcomes. We test whether meaning in life is associated with risk of cognitive impairment using data from a large, multi-national study.
METHODS
Participants (N = 22,514) were from the Survey of Health, Ageing and Retirement in Europe (SHARE). Participants from 14 countries reported on their meaning in life. Cognitive impairment was derived from performance on cognitive tasks administered at baseline and at up to three follow-up waves (waves 2-6 assessed between 2010-2015).
RESULTS
Lack of meaning in life was associated with a more than 20 % increased risk of incident cognitive impairment over the up to 9-year follow-up (Hazard Ratio = 1.24; 95 % Confidence Interval = 1.17-1.31). Further, compared to participants who reported often feeling meaning in life, participants who reported never feeling meaning in life were at an approximately 75 % increased risk of impairment (Hazard Ratio = 1.75, 95 % Confidence Interval = 1.19-2.57). The association between meaning in life and risk of cognitive impairment was apparent across four regions of Europe (Northern, Southern, Eastern, Western) and in Israel and was not moderated by sociodemographic characteristics.
CONCLUSIONS
Reporting lower meaning in one's life is associated with risk of incident cognitive impairment. Meaning may be a potential target of intervention for healthier cognitive aging.

Identifiants

pubmed: 32182537
pii: S0167-4943(20)30027-3
doi: 10.1016/j.archger.2020.104033
pmc: PMC7211110
mid: NIHMS1576781
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

104033

Subventions

Organisme : NIA NIH HHS
ID : HHSN271201300071C
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG053297
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG057917
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG064952
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None of the authors has a conflict of interest to report.

Références

Health Psychol Rev. 2017 Dec;11(4):387-418
pubmed: 28488471
J Health Psychol. 2016 Jun;21(6):962-71
pubmed: 25104777
Am J Epidemiol. 2008 Apr 1;167(7):820-30
pubmed: 18263600
Arch Gerontol Geriatr. 2017 Nov;73:120-124
pubmed: 28802214
JAMA Psychiatry. 2017 Oct 1;74(10):1039-1045
pubmed: 28813554
Arch Gen Psychiatry. 2010 Mar;67(3):304-10
pubmed: 20194831
Br J Psychol. 1992 Feb;83 ( Pt 1):133-45
pubmed: 1559144
Aging Ment Health. 2003 May;7(3):186-94
pubmed: 12775399
Psychol Aging. 2007 Sep;22(3):456-69
pubmed: 17874947
Psychol Sci. 2014 Feb;25(2):422-30
pubmed: 24335603
Int J Geriatr Psychiatry. 2018 May;33(5):743-747
pubmed: 29314273
JAMA Intern Med. 2017 Jan 1;177(1):51-58
pubmed: 27893041
J Am Geriatr Soc. 2016 Nov;64(11):2263-2269
pubmed: 27696342
J Gerontol B Psychol Sci Soc Sci. 2018 Oct 26;:
pubmed: 30365023
J Gerontol B Psychol Sci Soc Sci. 2009 Jun;64(4):517-27
pubmed: 19515991
Health Econ Rev. 2017 Dec 01;7(1):44
pubmed: 29196914
Aging Ment Health. 2019 Mar;23(3):357-364
pubmed: 29282997
Neurobiol Aging. 2019 Nov;83:124-129
pubmed: 31732015
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Age Ageing. 2017 Jan 20;46(1):71-77
pubmed: 28181637
Psychooncology. 2010 Dec;19(12):1340-7
pubmed: 20878857
Alzheimers Dement. 2014 Mar;10(2):179-86
pubmed: 23706517
Lancet Neurol. 2020 Mar;19(3):255-265
pubmed: 31813850
Int J Epidemiol. 2013 Aug;42(4):992-1001
pubmed: 23778574
Neurobiol Aging. 2013 Apr;34(4):1045-50
pubmed: 23040035
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2017 Nov;24(6):662-671
pubmed: 27819520
Cancer. 2019 Jul 15;125(14):2383-2393
pubmed: 31034600
Arch Gen Psychiatry. 2012 May;69(5):499-505
pubmed: 22566582
Am J Geriatr Psychiatry. 2019 Jun;27(6):593-601
pubmed: 30824327

Auteurs

Angelina R Sutin (AR)

Florida State University College of Medicine, United States. Electronic address: angelina.sutin@med.fsu.edu.

Martina Luchetti (M)

Florida State University College of Medicine, United States.

Yannick Stephan (Y)

Euromov, University of Montpellier, France.

Antonio Terracciano (A)

Florida State University College of Medicine, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH